17:48 uur 07-09-2022

Exscientia presenteert op komende investeerdersconferenties in september

OXFORD, Engeland–(BUSINESS WIRE)– Exscientia (Nasdaq: EXAI) heeft vandaag aangekondigd dat het management van het bedrijf in september zal deelnemen aan de volgende beleggersconferenties:

Morgan Stanley jaarlijkse Global Healthcare Conference:

Datum: woensdag 14 september 2022

Tijd: 15.35 uur BST / 10:35 uur EST

Locatie: New York, New York

Deelnemers: Ben Taylor, CFO & Chief Strategy Officer en Dave Hallett, Chief Operations Officer

BofA Securities Global Healthcare Conference:

 Datum: donderdag 15 september 2022

Tijd: 15.05 uur BST / 10:05 uur EST

Locatie: Londen, Verenigd Koninkrijk

Deelnemers: Andrew Hopkins, DPhil., oprichter en CEO van Exscientia, en Garry Pairaudeau, Chief Technology Officer

Exscientia to Present at Upcoming Investor Conferences in September

OXFORD, England–(BUSINESS WIRE)– Exscientia (Nasdaq: EXAI) today announced that Company management will participate in the following investor conferences in September:

Morgan Stanley Annual Global Healthcare Conference:

Date: Wednesday, September 14, 2022

Time: 3:35 p.m. BST / 10:35 a.m. EST

Location: New York, New York

Participants: Ben Taylor, CFO & Chief Strategy Officer and Dave Hallett, Chief Operations Officer

BofA Securities Global Healthcare Conference:

Date: Thursday, September 15, 2022

Time: 3:05 p.m. BST / 10:05 a.m. EST

Location: London, United Kingdom

Participants: Andrew Hopkins, DPhil., Exscientia’s founder and CEO, and Garry Pairaudeau, Chief Technology Officer

Live webcasts of the presentations will be available on the Company’s website, under the “Investors & Media” section at www.investors.exscientia.ai. Archived replays of the webcasts will be available for approximately 30 days following the presentation.

About Exscientia

Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.

Exscientia is headquartered in Oxford (England, U.K.), with offices in Vienna (Austria), Dundee (Scotland, U.K.), Boston (Mass., U.S.), Miami (Fla., U.S.), Cambridge (England, U.K.), and Osaka (Japan).

Visit us at https://www.exscientia.ai or follow us on Twitter @exscientiaAI.


Sara Sherman


Amanda Galgay


Check out our twitter: @NewsNovumpr